1-7 of 7
Peter van Sluis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors

Ellen M. Westerhout, Mohamed Hamdi, Peter Stroeken, Natalia E. Nowakowska, Arjan Lakeman, Jennemiek van Arkel, Nancy E. Hasselt, Boris Blejlevens, Nurdan Akogul, Franciska Haneveld, Alvin Chan, Peter van Sluis, Danny Zwijnenburg, Richard Volckmann, Carel JM van Noesel, Igor Adameyko, Tim van Gronigen, Jan Koster, Linda J. Valentijn, Johan van Nes, Rogier Versteeg
Journal: Cancer Research
Cancer Res (2022) 82 (14): 2657.
https://doi.org/10.1158/0008-5472.CAN-22-1915
Published: 18 July 2022
View article titled, Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
Open the PDF for Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors in another window
Journal Articles

Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors

Ellen M. Westerhout, Mohamed Hamdi, Peter Stroeken, Natalia E. Nowakowska, Arjan Lakeman, Jennemiek van Arkel, Nancy E. Hasselt, Boris Bleijlevens, Nurdan Akogul, Franciska Haneveld, Alvin Chan, Peter van Sluis, Danny Zwijnenburg, Richard Volckmann, Carel J.M. van Noesel, Igor Adameyko, Tim van Groningen, Jan Koster, Linda J. Valentijn, Johan van Nes, Rogier Versteeg
Journal: Cancer Research
Cancer Res (2022) 82 (3): 484–496.
https://doi.org/10.1158/0008-5472.CAN-21-1621
Published: 02 February 2022
View article titled, Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
Open the PDF for Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors in another window
Includes: Supplementary data
Journal Articles

RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma

Thomas F. Eleveld, Linda Schild, Jan Koster, Danny A. Zwijnenburg, Lindy K. Alles, Marli E. Ebus, Richard Volckmann, Godelieve A. Tijtgat, Peter van Sluis, Rogier Versteeg, Jan J. Molenaar
Journal: Cancer Research
Cancer Res (2018) 78 (21): 6297–6307.
https://doi.org/10.1158/0008-5472.CAN-18-1045
Published: 01 November 2018
View article titled, RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma
Open the PDF for RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Derek A. Oldridge, Thomas F. Eleveld, Virginie Bernard, Jan Koster, Leo C. Daage, Sharon J. Diskin, Linda Schild, Nadia B. Bentahar, Angela Bellini, Mathieu Chicard, Eve Lapouble, Valérie Combaret, Patricia Legoix-Né, Jean Michon, Trevor J. Pugh, Lori S. Hart, JulieAnn Rader, Edward F. Attiyeh, Jun S. Wei, Shile Zhang, Arlene Naranjo, Julie M. Gastier-Foster, Michael D. Hogarty, Malcolm A. Smith, Jaime G. Auvil, Thomas B. K. Watkins, Danny A. Zwijnenburg, Marli E. Ebus, Peter van Sluis, Anne Hakkert, Esther van Wezel, C. Ellen van der Schoot, Ellen M. Westerhout, Johannes H. Schulte, Godelieve A. Tytgat, M. Emmy M. Dolman, Isabelle Janoueix-Lerosey, Daniela S. Gerhard, Huib N. Caron, Olivier Delattre, Javed Khan, Rogier Versteeg, Gudrun Schleiermacher, John M. Maris, Jan J. Molenaar
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2980.
https://doi.org/10.1158/1538-7445.AM2015-2980
Published: 01 August 2015
View article titled, Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Journal Articles

Abstract LB-209: Neuroblastoma is biphasic with classical neuro-epithelial cells and chemoresistant mesenchymal cells controlled by PRRX1-NOTCH signaling

Tim van Groningen, Natalia E. Nowakowska, Nurdan Akogul, Marloes Broekmans, Johannes Bras, Jan Booij, Marli E. Ebus, Jan J. Molenaar, Ellen M. Westerhout, Mohamed Hamdi, Peter van Sluis, Jan Koster, Bart A. Westerman, Godelieve A. Tytgat, Rogier Versteeg, Johan van Nes
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): LB-209.
https://doi.org/10.1158/1538-7445.AM2015-LB-209
Published: 01 August 2015
View article titled, Abstract LB-209: Neuroblastoma is biphasic with classical neuro-epithelial cells and chemoresistant mesenchymal cells controlled by PRRX1-NOTCH signaling
Journal Articles

Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma

Jan J. Molenaar, Marli E. Ebus, Jan Koster, Peter van Sluis, Carel J.M. van Noesel, Rogier Versteeg, Huib N. Caron
Journal: Cancer Research
Cancer Res (2008) 68 (8): 2599–2609.
https://doi.org/10.1158/0008-5472.CAN-07-5032
Published: 15 April 2008
View article titled, Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma
Open the PDF for Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma in another window
Journal Articles

Identification and molecular characterization of medulloblastoma subtypes

Marcel Kool, Jan Koster, Jens Bunt, Nancy Hasselt, Peter van Sluis, Wolfgang Hartmann, Torsten Pietsch, David Ellison, Steve Clifford, Huib Caron, Rogier Versteeg
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2938.
Published: 01 May 2007
View article titled, Identification and molecular characterization of medulloblastoma subtypes